Core Viewpoint - Jiangsu Changqing Agricultural Chemical Co., Ltd. held its third meeting of the ninth board of directors on August 7, 2025, where several key resolutions were passed, including the approval of the 2025 semi-annual report and the special report on the use of raised funds [1][2]. Group 1: Meeting Resolutions - The board approved the 2025 semi-annual report and its summary, which will be published on August 11, 2025 [1][2]. - The board approved the special report on the storage and use of raised funds for the first half of 2025, also to be published on August 11, 2025 [2]. - The board approved the proposal to cancel the supervisory board and amend the company’s articles of association, which will be submitted for review at the first extraordinary general meeting of 2025 [2][3]. - The board approved the proposal to formulate and amend certain governance systems, with the full text to be published on August 11, 2025 [3]. - The board approved the proposal to change part of the investment projects funded by raised funds, which will also be submitted for review at the first extraordinary general meeting of 2025 [4]. - The board decided to hold the first extraordinary general meeting of 2025 on September 5, 2025, combining on-site and online voting [5].

Core Points - The company held the third meeting of the ninth supervisory board on August 7, 2025, where all members confirmed the authenticity and completeness of the disclosed information [1][2] - The supervisory board approved the 2025 semi-annual report and its summary, affirming that the report accurately reflects the company's actual situation without any misleading statements [1][2] - The board also approved the special report on the use of raised funds for the first half of 2025, confirming compliance with relevant regulations [2] - A proposal to change part of the investment projects funded by raised funds was approved, specifically changing the project from "annual production of 3,500 tons of glyphosate raw materials" to "annual production of 1,000 tons of prothioconazole raw materials" and "annual production of 4,200 tons of pyrethroid series products" [2][3] - The decision to change the investment projects is based on the company's actual situation and is expected to improve the efficiency of fund usage and optimize resource allocation [2][3]

Meeting Information - The company will hold its first extraordinary general meeting of shareholders in 2025 on September 5, 2025, at 14:00 [1] - The meeting will include both on-site and online voting options for shareholders [2][4] Voting Procedures - Shareholders can vote in person or authorize others to attend and vote on their behalf [2][3] - Online voting will be available through the Shenzhen Stock Exchange system and internet platform from 9:15 to 15:00 on the meeting day [1][4] Shareholder Eligibility - All shareholders registered with the China Securities Depository and Clearing Corporation Limited by the end of trading on September 1, 2025, are eligible to attend the meeting [2][3] Agenda Items - The meeting will review proposals that comply with the Company Law and the company's articles of association [2][3] - Specific proposals will be detailed in the official announcements published on August 11, 2025 [2] Registration Process - Individual shareholders must present their ID and securities account card for registration, while representatives must provide additional documentation [3][4] - Remote shareholders can register via mail or fax before the deadline of September 4, 2025 [3] Additional Information - The company has provided detailed instructions for online voting and registration in the attached documents [4][5]

General Overview - The document outlines the working rules of the Compensation and Assessment Committee of Jiangsu Changqing Agricultural Chemical Co., Ltd, approved on August 7, 2025, during the third meeting of the ninth board of directors [1] Composition of the Committee - The Compensation and Assessment Committee consists of three directors, with independent directors making up more than half and serving as the convener [2] - Committee members are nominated by the chairman, more than half of the independent directors, or more than one-third of the directors, and elected by the board [2] Responsibilities and Authority - The committee is responsible for establishing assessment standards for directors and senior management, reviewing compensation policies, and making recommendations on various matters including compensation and incentive plans [2][3] - The board has the authority to reject any compensation plans that may harm shareholder interests, and any unadopted recommendations must be documented and disclosed [3] Decision-Making Procedures - The human resources department coordinates the preparation for the committee's decisions, providing necessary financial and performance data [3] - The evaluation process for directors and senior management includes self-assessment and performance evaluation based on established standards [3] Meeting Rules - The committee holds regular meetings at least once a year, with notifications sent seven days in advance, and can convene temporary meetings as needed [4] - A quorum requires attendance from at least two-thirds of the members, and decisions must be approved by a majority [4] Confidentiality and Reporting - All attendees of the committee meetings are bound by confidentiality regarding the discussed matters [5] - Resolutions and voting results from the meetings must be reported in writing to the board of directors [5]

Summary of Key Points Core Viewpoint The company, Jiangsu Changqing Agricultural Chemical Co., Ltd., is changing part of its fundraising investment projects to optimize its industrial layout and improve the efficiency of fund usage in response to market conditions and strategic planning [1][10]. Group 1: Fundraising Overview - The company issued 9.138 million convertible bonds with a total fundraising amount of 913.8 million yuan, net of issuance costs [1][2]. - The funds were initially allocated for various projects, including the production of herbicides and pesticides [2]. Group 2: Project Change Details - The project "Annual Production of 3,500 Tons of Glyphosate Raw Material" will be changed to "Annual Production of 1,000 Tons of Prothioconazole Raw Material" and "Annual Production of 4,200 Tons of Pyrethroid Series Products" [3][4]. - The change represents 30.79% of the total fundraising amount [3]. Group 3: Market Context - Glyphosate has seen a significant drop in price from 270,000 yuan/ton in 2022 to below 50,000 yuan/ton currently due to increased competition and market saturation [4]. - The global market for Prothioconazole reached 1.328 billion USD in 2023, indicating strong demand for this product [4]. Group 4: New Project Financials - The Prothioconazole project has a total investment of 147 million yuan, with expected annual sales revenue of 119.3 million yuan and a net profit of 30.16 million yuan upon reaching full production [5][8]. - The Pyrethroid project has a total investment of 120 million yuan, with projected annual sales revenue of 109 million yuan and a net profit of 26.86 million yuan [6][8]. Group 5: Approval Process - The board of directors approved the project changes on August 7, 2025, and the changes will be submitted for shareholder approval [9][10]. - The changes comply with relevant regulations and do not harm the interests of the company or its shareholders [10][11].

长青股份8月10日披露半年报，公司上半年实现营业收入20.83亿元，同比增长7.28%；归属于上市公司 股东的净利润4227.78万元，上年同期1941.55万元，同比增长117.75%；基本每股收益0.0676元。 ...

（文章来源：每日经济新闻） 长青股份8月10日晚间发布公告称，公司第九届第三次董事会会议于2025年8月7日在公司会议室以现场 方式召开。会议审议了《2025年半年度报告及其摘要》等文件。 ...

民生证券股份有限公司 关于江苏长青农化股份有限公司变更部分募集资金投资项目的 核查意见 民生证券股份有限公司（以下简称"民生证券"或"保荐机构"）作为江苏长青 农化股份有限公司（以下简称"长青股份"或"公司"）持续督导的保荐机构，民生 证券根据《证券发行上市保荐业务管理办法》《深圳证券交易所上市规则》《上市 公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》、《深圳证券 交易所上市公司自律监管指引第 13 号——保荐业务》、《深圳证券交易所上市公 司自律监管指引第 1 号——主板上市公司规范运作》等相关法律法规的规定和要 求，通过定期的现场检查、资料查阅、沟通访谈及列席重要会议等方式，对长青 股份变更部分募集资金投资项目事项进行了核查，具体情况如下： 一、募集资金的基本情况 经中国证券监督管理委员会《关于核准江苏长青农化股份有限公司公开发行 可转换公司债券的批复》（证监许可[2018]2097 号）核准，公司于 2019 年 2 月 27 日向社会公开发行 913.8 万张可转换公司债券，每张面值 100 元，公开发行可转 债募集资金总额为 913,800,000.00 元，扣除承销费、保荐费等 ...

江苏长青农化股份有限公司 董事会议事规则 二零二五年八月 1 第七章 董事会经费 第八章 附则 董事会议事规则 （2025 年 8 月 7 日江苏长青农化股份有限公司 第九届董事会第三次会议审议通过） 目 录 第一章 总则 2 第二章 董事会会议的提案、通知 第三章 董事会会议的召集、主持、召开 第四章 董事会会议的表决、决议 第五章 董事会会议记录、档案管理 第六章 董事会会议决议的执行 第一章 总则 第一条 为明确江苏长青农化股份有限公司（以下简称"公司"）董事会的 职责权限，进一步规范公司董事会的议事方式和决策程序，保障董事会决策合法 化、科学化、制度化，充分发挥董事会的经营决策中心作用，根据《中华人民共 和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下 简称"《证券法》"）、《上市公司治理准则》、《深圳证券交易所股票上市规 则》、《深圳证券交易所上市公司自律监管指引第 1 号—主板上市公司规范运作》 等法律、行政法规、规范性文件以及本公司章程的规定，制订本规则。 第二条 公司依法设立董事会，董事会是公司的经营决策机构，对股东会负 责，执行股东会的决议。董事会履行其职责时应严格遵守 ...

1 江苏长青农化股份有限公司 江苏长青农化股份有限公司 独立董事工作制度 独立董事工作制度 （2025 年 8 月 7 日江苏长青农化股份有限公司 第九届董事会第三次会议审议通过） 第一章 总则 二零二五年八月 第一条 为完善江苏长青农化股份有限公司（以下简称"公司"）治理结构，促 进公司规范运作，切实保护公司及股东的利益，根据《中华人民共和国公司法》（以 下简称"《公司法》"）、《中华人民共和国证券法》、《上市公司独立董事管理办法》、 《上市公司治理准则》、《深圳证券交易所股票上市规则》、《深圳证券交易所上市公 司自律监管指引第 1 号—主板上市公司规范运作》等有关法律法规、规范性文件和 《江苏长青农化股份有限公司章程》（以下简称"公司章程"）的有关规定，并结合 公司实际情况，特制定本制度。 第二条 独立董事是指不在公司担任除董事外的任何其他职务，并与公司及其主 要股东、实际控制人不存在直接或者间接利害关系，或者其他可能影响其进行独立 客观判断关系的董事。 第三条 独立董事对公司及全体股东负有忠实与勤勉义务。独立董事应当按照法 律、行政法规、中国证监会规定、深圳证券交易所业务规则和公司章程的规定，认 真履行 ...